|
Home | Medical-Newswire.Com:
|
(EMAILWIRE.COM, November 08, 2007 ) Los Angeles, CA -- Tony Golan, Chief Technical Analyst with StockProfit.com, has featured PURE Bioscience (OTCBB: PURE) as the StockProfit.com mid-week Small-Cap Highlight for the week of November 5th, 2007. According to Mr. Golan, “Late last year and going all the way into this past Spring, PURE was non-trending, as can be evident by the swings above and below the 200-day moving average (the red line in the chart above). However, all that changed this past August, when PURE hit a low of 2.72 at the 200-day moving average and turned back up sharply. PURE has since rallied to a high of 8.59 in late October.”For the full details, visit http://www.stockprofit.com/smallcapRecent NewsNovember 07, 2007 - SAN DIEGO --PURE Bioscience (OTCBB:PURE) today announced it has received EPA registration of expanded bacterial and viral efficacy claims for its silver dihydrogen citrate (SDC)-based disinfectant (Axen30™). The amended label now includes kill claims against eight new organisms, including Avian Influenza A (Bird Flu), Human Corona virus (SARS surrogate), Feline Calicivirus (Norovirus), Rotavirus, Campylobacter jejuni and Acinetobacter baumannii as well as two additional strains of MRSA: Community Associated MRSA (CA-MRSA) and Community Associated PVL Positive MRSA (PVL MRSA). Powerful Weapon against Resistant Bacteria Regarding the expanded bacterial claims, Michael L. Krall, President and CEO of PURE Bioscience, stated, “PURE Bioscience has long recognized the importance of controlling organisms responsible for nosocomial infections, particularly those that have become resistant to antibiotics. Our SDC-based disinfectant already carried a two-minute claim for Methicillin-resistant Staphylococcus aureus (MRSA). It now carries claims against two additional resistant strains of Staph, Community Associated MRSA (CA-MRSA) and Community Associated PVL Positive MRSA (CA-MRSA, PVL Positive), eliminating both organisms in just two minutes.” Also added to the expanded label are two-minute kill claims on Campylobacter jejuni, one of the leading causative agents for human gastroenteritis worldwide, and Acinetobacter baumannii, an opportunistic nosocomial pathogen responsible for serious infections among soldiers wounded in Iraq and Afghanistan. Timely New Viral Efficacy Claims Expanded viral efficacy claims for PURE’s SDC-based disinfectant include a three-minute kill against Human Corona virus and Rotavirus and a ten-minute kill against Norovirus and Avian Influenza A. The Human Corona virus infects the gastrointestinal tract and the upper respiratory tract. The most notable of the Human Corona viruses is the SARS-CoV strain, which causes SARS (Severe Acute Respiratory Syndrome). Rotavirus is the most frequent cause of severe diarrhea among children and leads to the hospitalization of approximately 55,000 children in the Untied States each year. Noroviruses cause gastroenteritis, more commonly referred to as “stomach flu.” Norovirus is highly contagious and spreads rapidly throughout closed environments. Avian Influenza A viruses cause Avian influenza, often referred to as “bird flu.” Bird flu is a naturally occurring infection primarily in birds; however, infections with these viruses can occur in humans. Krall also commented on the new viral claims, “The standard viral kill time for disinfectants is 10 minutes, and our prior viral tests were performed to meet that standard. Based on the most recent three-minute viral test results against Human Corona virus and Rotavirus, we intend to begin retesting the other viruses and expect this SDC-based disinfectant to demonstrate quicker kill times. Following successful testing, we plan to submit the updated information to the EPA for registration.” Krall concluded, “Earlier this year, we identified significant and growing needs in the marketplace. In February we initiated independent third party laboratory testing to establish the data for these new claims, and the EPA label amendment was filed immediately upon completion of the battery of tests. With the recent issuance of the EPA’s registration of our expanded claims, we feel we are now well positioned to provide an even more comprehensive solution to help combat very serious world-wide health challenges.” SDC is an electrolytically generated source of stabilized ionic silver. As a platform technology, SDC is distinguished from competitors in the marketplace because of its superior efficacy, low toxicity and the inability of bacteria to form a resistance to it. The first new disinfectant active to be registered by the EPA in more than 30 years, SDC-based products are antiviral, antifungal and antibacterial, including a 30-second kill and 24-hour residual protection against standard indicator bacteria and a two-minute kill claim on MRSA (Methicillin-resistant Staphylococcus aureus), CA-MRSA, PVL-MRSA and VRE (Vancomycin resistant Enterococcus faecium). Moreover, SDC-based disinfectants are odorless, colorless, non-corrosive, non-flammable and are compatible with other disinfecting and cleaning chemicals. Private label SDC-based hard surface disinfectant products are currently available through a number of PURE’s distributors and are ideal for use not only as a household disinfectant but also in hospitals, schools, prisons and other closed population environments.About StockProfit.comStockProfit.com, is dedicated to using technical analysis to identify stocks in particularly powerful up-trends, then pinpoint the optimal time to enter these stocks, in addition to providing an online resource for aggressive risk-tolerant market participants who wish to learn about select growth companies and other ideas that could offer potentially superior investment returns. Research and due diligence tools such as Small Cap Highlights, Company Profiles, Technical Trading Alerts, detailed investment opinion reports, and regular email updates of Featured Companies are some of the services we provide to our readership. For more information, visit http://www.stockprofit.com.Disclaimer: Copyright© 2007 StockProfit™. All rights reserved. StockProfit™ is an independent electronic publication providing information on select public companies. StockProfit™ is not a registered investment advisor or broker-dealer. There is a risk of loss in all of trading. Past performance is no indication, nor guarantee of future results. The information contained herein is believed to be accurate. This update is provided as an information service only, and the statements and opinions in this update should not be construed as an offer or solicitation to buy or sell any security. In no event shall StockProfit™ and/or its publisher, P.A. Relations or any of its employees or affiliates, be liable for any direct, incidental, consequential, indirect or punitive damages whatsoever arising out of the use of the Information, or for any errors or omissions in the content thereof, including, but not limited to, from any investment loss, damage or expense incurred by any investor resulting from the Information, or from the purchase or sale of any profiled company or any company which we make commentary. We recommend using good-'till-cancelled stop orders to minimize losses in the event of an adverse price movement. We have not been compensated by company(ies) mentioned above in any way. We do not hold any positions whatsoever in the above mentioned company(ies). CONTACT: Alan Klitenic , P.A. Relations. Inc. TEL: 818 334 4469 EMAIL: amk@stockprofit.com.
P.A. Relations
alan klitenic
amk@stockprofit.com 
Source: EmailWire.com
|
|
|
|
